世界の皮膚糸状菌性爪真菌症治療（DOT）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1805 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、皮膚糸状菌性爪真菌症治療（DOT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口療法）、用途別市場規模（病院、皮膚科・足病クリニック、独立薬局、通信販売薬局、ドラッグストア）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮膚糸状菌性爪真菌症治療（DOT）の市場動向 ・企業の競争状況、市場シェア ・皮膚糸状菌性爪真菌症治療（DOT）の種類別市場規模（局所、経口療法） ・皮膚糸状菌性爪真菌症治療（DOT）の用途別市場規模（病院、皮膚科・足病クリニック、独立薬局、通信販売薬局、ドラッグストア） ・皮膚糸状菌性爪真菌症治療（DOT）の北米市場規模2016-2027（アメリカ、カナダ） ・皮膚糸状菌性爪真菌症治療（DOT）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮膚糸状菌性爪真菌症治療（DOT）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮膚糸状菌性爪真菌症治療（DOT）の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮膚糸状菌性爪真菌症治療（DOT）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Galderma、Bausch Health、Novartis、Pfizer、Janssen） ・結論

Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market. By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for about 70% share of the total global dermatophytic onychomycosis market revenue by 2025.

Market Analysis and Insights: Global Dermatophytic Onychomycosis Therapeutics (DOT) Market
The global Dermatophytic Onychomycosis Therapeutics (DOT) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermatophytic Onychomycosis Therapeutics (DOT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermatophytic Onychomycosis Therapeutics (DOT) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermatophytic Onychomycosis Therapeutics (DOT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermatophytic Onychomycosis Therapeutics (DOT) market.

Global Dermatophytic Onychomycosis Therapeutics (DOT) Scope and Market Size
Dermatophytic Onychomycosis Therapeutics (DOT) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermatophytic Onychomycosis Therapeutics (DOT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Topical
Oral Therapy

Segment by Application
Hospitals
Dermatology And Podiatry Clinics
Independent Pharmacies
Mail Order Pharmacies
Drug Stores

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Galderma
Bausch Health
Novartis
Pfizer
Janssen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Topical
1.2.3 Oral Therapy
1.3 Market by Application
1.3.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Dermatology And Podiatry Clinics
1.3.4 Independent Pharmacies
1.3.5 Mail Order Pharmacies
1.3.6 Drug Stores
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Perspective (2016-2027)
2.2 Dermatophytic Onychomycosis Therapeutics (DOT) Growth Trends by Regions
2.2.1 Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dermatophytic Onychomycosis Therapeutics (DOT) Historic Market Share by Regions (2016-2021)
2.2.3 Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Regions (2022-2027)
2.3 Dermatophytic Onychomycosis Therapeutics (DOT) Industry Dynamic
2.3.1 Dermatophytic Onychomycosis Therapeutics (DOT) Market Trends
2.3.2 Dermatophytic Onychomycosis Therapeutics (DOT) Market Drivers
2.3.3 Dermatophytic Onychomycosis Therapeutics (DOT) Market Challenges
2.3.4 Dermatophytic Onychomycosis Therapeutics (DOT) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Players by Revenue
3.1.1 Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Players by Revenue (2016-2021)
3.1.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Players (2016-2021)
3.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermatophytic Onychomycosis Therapeutics (DOT) Revenue
3.4 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Concentration Ratio
3.4.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Therapeutics (DOT) Revenue in 2020
3.5 Dermatophytic Onychomycosis Therapeutics (DOT) Key Players Head office and Area Served
3.6 Key Players Dermatophytic Onychomycosis Therapeutics (DOT) Product Solution and Service
3.7 Date of Enter into Dermatophytic Onychomycosis Therapeutics (DOT) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dermatophytic Onychomycosis Therapeutics (DOT) Breakdown Data by Type
4.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Historic Market Size by Type (2016-2021)
4.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Type (2022-2027)

5 Dermatophytic Onychomycosis Therapeutics (DOT) Breakdown Data by Application
5.1 Global Dermatophytic Onychomycosis Therapeutics (DOT) Historic Market Size by Application (2016-2021)
5.2 Global Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2016-2027)
6.2 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type
6.2.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021)
6.2.2 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027)
6.2.3 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2027)
6.3 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application
6.3.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021)
6.3.2 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027)
6.3.3 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2027)
6.4 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country
6.4.1 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2016-2021)
6.4.2 North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2016-2027)
7.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type
7.2.1 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021)
7.2.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027)
7.2.3 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2027)
7.3 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application
7.3.1 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021)
7.3.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027)
7.3.3 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2027)
7.4 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country
7.4.1 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2016-2021)
7.4.2 Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2016-2027)
8.2 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type
8.2.1 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2027)
8.3 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application
8.3.1 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2027)
8.4 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Region
8.4.1 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2016-2027)
9.2 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type
9.2.1 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021)
9.2.2 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027)
9.2.3 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2027)
9.3 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application
9.3.1 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021)
9.3.2 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027)
9.3.3 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2027)
9.4 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country
9.4.1 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2016-2021)
9.4.2 Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (2016-2027)
10.2 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type
10.2.1 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2027)
10.3 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application
10.3.1 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2027)
10.4 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country
10.4.1 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Galderma
11.1.1 Galderma Company Details
11.1.2 Galderma Business Overview
11.1.3 Galderma Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.1.4 Galderma Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
11.1.5 Galderma Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.2.4 Bausch Health Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
11.2.5 Bausch Health Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.3.4 Novartis Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.4.4 Pfizer Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Janssen
11.5.1 Janssen Company Details
11.5.2 Janssen Business Overview
11.5.3 Janssen Dermatophytic Onychomycosis Therapeutics (DOT) Introduction
11.5.4 Janssen Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
11.5.5 Janssen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Topical
Table 3. Key Players of Oral Therapy
Table 4. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Regions (2016-2021)
Table 8. Global Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Regions (2022-2027)
Table 10. Dermatophytic Onychomycosis Therapeutics (DOT) Market Trends
Table 11. Dermatophytic Onychomycosis Therapeutics (DOT) Market Drivers
Table 12. Dermatophytic Onychomycosis Therapeutics (DOT) Market Challenges
Table 13. Dermatophytic Onychomycosis Therapeutics (DOT) Market Restraints
Table 14. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Players (2016-2021)
Table 16. Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) as of 2020)
Table 17. Ranking of Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Dermatophytic Onychomycosis Therapeutics (DOT) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dermatophytic Onychomycosis Therapeutics (DOT) Product Solution and Service
Table 21. Date of Enter into Dermatophytic Onychomycosis Therapeutics (DOT) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Type (2016-2021)
Table 25. Global Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Application (2016-2021)
Table 29. Global Dermatophytic Onychomycosis Therapeutics (DOT) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Galderma Company Details
Table 62. Galderma Business Overview
Table 63. Galderma Dermatophytic Onychomycosis Therapeutics (DOT) Product
Table 64. Galderma Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021) & (US$ Million)
Table 65. Galderma Recent Development
Table 66. Bausch Health Company Details
Table 67. Bausch Health Business Overview
Table 68. Bausch Health Dermatophytic Onychomycosis Therapeutics (DOT) Product
Table 69. Bausch Health Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021) & (US$ Million)
Table 70. Bausch Health Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Dermatophytic Onychomycosis Therapeutics (DOT) Product
Table 74. Novartis Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Dermatophytic Onychomycosis Therapeutics (DOT) Product
Table 79. Pfizer Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Janssen Company Details
Table 82. Janssen Business Overview
Table 83. Janssen Dermatophytic Onychomycosis Therapeutics (DOT) Product
Table 84. Janssen Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021) & (US$ Million)
Table 85. Janssen Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type: 2020 VS 2027
Figure 2. Topical Features
Figure 3. Oral Therapy Features
Figure 4. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Dermatology And Podiatry Clinics Case Studies
Figure 7. Independent Pharmacies Case Studies
Figure 8. Mail Order Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. Dermatophytic Onychomycosis Therapeutics (DOT) Report Years Considered
Figure 11. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Regions: 2020 VS 2027
Figure 14. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Regions (2022-2027)
Figure 15. Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Players in 2020
Figure 16. Global Top Dermatophytic Onychomycosis Therapeutics (DOT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis Therapeutics (DOT) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Therapeutics (DOT) Revenue in 2020
Figure 18. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Type (2016-2021)
Figure 19. Global Dermatophytic Onychomycosis Therapeutics (DOT) Revenue Market Share by Type (2022-2027)
Figure 20. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2016-2027)
Figure 22. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2016-2027)
Figure 23. North America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Country (2016-2027)
Figure 24. United States Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2016-2027)
Figure 28. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2016-2027)
Figure 29. Europe Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Country (2016-2027)
Figure 30. Germany Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Region (2016-2027)
Figure 40. China Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2016-2027)
Figure 48. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2016-2027)
Figure 49. Latin America Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Country (2016-2027)
Figure 50. Mexico Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Dermatophytic Onychomycosis Therapeutics (DOT) Market Share by Country (2016-2027)
Figure 56. Turkey Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Dermatophytic Onychomycosis Therapeutics (DOT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Galderma Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
Figure 60. Bausch Health Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
Figure 63. Janssen Revenue Growth Rate in Dermatophytic Onychomycosis Therapeutics (DOT) Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---